Lupin soars on getting USFDA’s nod for Liraglutide and Glucagon Injectable Products
Lupin is currently trading at Rs. 1944.70, up by 24.25 points or 1.26% from its previous closing of Rs. 1920.45 on the BSE. The scrip opened at Rs. 1925.95 and has touched a high and low of Rs. 1956.00 and Rs. 1915.00 respectively. So far 7511 shares were traded on the counter. The BSE group … Read more



